Funded Tech Companies

STORM Therapeutics

STORM Therapeutics is a biopharmaceutical company, based in Cambridge. Financial backing came from Pfizer Venture Investments, Taiho Ventures and Cambridge Innovation Capital.

Company Overview

Company Name
STORM Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Babraham Research Campus Moneta Building
Cambridge, CB22 3AT
UK
Email Address

Company Background Information

Overview
STORM Therapeutics is a University of Cambridge spin-out, translating the groundbreaking work of Professors Tony Kouzarides and Eric Miska in RNA epigenetics into the discovery of first-in-class drugs in oncology and other diseases.
Profile
STORM Therapeutics LinkedIn Company Profile
Social Media
STORM Therapeutics Company Twitter Account
Company News
STORM Therapeutics News
Facebook
STORM Therapeutics on Facebook
YouTube
STORM Therapeutics on YouTube
Last Transaction
12/14/2022

Financing History

Date
Type
Amount
Venture Equity
$30,000,000
Venture Equity
$5,430,760


Management Team

Title
Name
Email & Social
Chief Executive Officer
Keith Blundy
  Keith Blundy LinkedIn Profile  Keith Blundy Twitter Account  Keith Blundy News  Keith Blundy on Facebook
Chief Scientific Officer
Oliver Rausch
  Oliver Rausch LinkedIn Profile  Oliver Rausch Twitter Account  Oliver Rausch News  Oliver Rausch on Facebook
Vice President
Wesley Blackaby
  Wesley Blackaby LinkedIn Profile  Wesley Blackaby Twitter Account  Wesley Blackaby News  Wesley Blackaby on Facebook
VP - Bus. Development
David Simmons
  David Simmons LinkedIn Profile  David Simmons Twitter Account  David Simmons News  David Simmons on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Storm Exchange | StormBlok Systems

 

Share this article

 


About Our VC Deals Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary